科瑞斯塔生物科技 KRYS
$300.88 +$0.63 (+0.21%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $300.88 0.00%
开盘$298.31
昨收$300.25
当日区间$297.52 – $305.60
成交量234.2K
市值$8.92B
市盈率（TTM）40.9
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$119.22M+24.1% YoY
营业利润$58.42M+48.3% YoY
净利润$54.77M+42.9% YoY
摊薄每股收益$1.79+38.8% YoY
自由现金流$71.22M+40.1% YoY
经营现金流$74.79M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率94.6%
营业利润率44.9%
净利率54.8%
净资产收益率20.1%
资产收益率18.3%
投入资本回报率18.5%
流动比率8.32
负债/资产比率9.4%
现金及投资$845.63M
总负债$7.05M
净现金（净负债）$838.59M
自由现金流/营收58.5%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $119.22M | $116.36M | $389.13M | $107.11M | $97.80M |
| 营业总收入 | $119.22M | $116.36M | $389.13M | $107.11M | $97.80M |
| 营业成本 | $6.44M | $6.32M | $23.05M | $6.59M | $4.26M |
| 毛利润 | $112.79M | $110.03M | $366.08M | $100.51M | $93.54M |
| 营业费用 | $54.37M | $56.35M | $204.79M | $56.24M | $52.16M |
| 销售及管理费用 | $39.85M | $41.01M | $146.74M | $41.45M | $37.58M |
| 研发费用 | $14.52M | $15.33M | $58.05M | $14.79M | $14.59M |
| 营业利润 | $58.42M | $53.69M | $161.30M | $44.27M | $41.37M |
| 非经营性利息净收入（支出） | $7.66M | $7.75M | $28.18M | $6.86M | $6.59M |
| 非经营性利息收入 | $7.66M | – | $28.18M | $6.86M | $6.59M |
| 税前利润 | $66.08M | $61.44M | $189.47M | $51.13M | $47.97M |
| 税费 | $11.31M | $5.51M | -$15.36M | -$269,000.00 | -$31.40M |
| 净利润 | $54.77M | $55.93M | $204.83M | $51.40M | $79.37M |
| 持续经营利润 | $54.77M | $55.93M | $204.83M | $51.40M | $79.37M |
| 归属母公司净利润 | $54.77M | $55.93M | $204.83M | $51.40M | $79.37M |
| 归属普通股股东净利润 | $54.77M | $55.93M | $204.83M | $51.40M | $79.37M |
| 基本每股收益 | $1.85 | $1.91 | $7.08 | $1.77 | $2.74 |
| 摊薄每股收益 | $1.79 | $1.83 | $6.84 | $1.70 | $2.66 |
| 其他财务成本合计 | – | -$7.75M | – | – | – |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.50B | $1.40B | $1.33B | $1.33B | $1.24B |
| 流动资产合计 | $1.06B | $1.02B | $1.02B | $1.02B | $925.65M |
| 现金及现金等价物与短期投资 | $845.63M | $823.41M | $827.79M | $827.79M | $731.07M |
| -现金及现金等价物 | $427.74M | $501.31M | $496.30M | $496.30M | $392.60M |
| -短期投资 | $417.89M | $322.09M | $331.49M | $331.49M | $338.47M |
| 应收款 | $138.66M | $127.02M | $127.43M | $127.43M | $129.63M |
| -应收账款 | $138.66M | $127.02M | $127.43M | $127.43M | $129.63M |
| 预付资产 | $15.31M | $10.64M | $14.01M | $14.01M | $10.10M |
| 存货 | $45.56M | $42.65M | $40.48M | $40.48M | $37.63M |
| 其他流动资产 | $14.49M | $16.03M | $14.91M | $14.91M | $17.21M |
| 非流动资产合计 | $441.00M | $377.23M | $309.19M | $309.19M | $314.44M |
| 固定资产净值 | $160.60M | $160.62M | $158.02M | $158.02M | $156.32M |
| -固定资产原值 | $196.97M | $194.39M | $189.30M | $189.30M | $185.49M |
| -累计折旧 | -$36.37M | -$33.77M | -$31.28M | -$31.28M | -$29.17M |
| 投资及预付款 | $257.29M | $193.49M | $128.07M | $128.07M | $133.11M |
| -可供出售证券 | $257.29M | $193.49M | $128.07M | $128.07M | $133.11M |
| 一年以上递延资产 | $22.82M | $22.82M | $22.82M | $22.82M | $24.68M |
| 其他非流动资产 | $284,000.00 | $300,000.00 | $287,000.00 | $287,000.00 | $333,000.00 |
| 负债合计 | $141.52M | $120.24M | $114.23M | $114.23M | $102.22M |
| 流动负债合计 | $127.40M | $107.80M | $102.94M | $102.94M | $91.27M |
| 应付款 | $21.35M | $17.20M | $14.16M | $14.16M | $11.64M |
| -应付账款 | $6.54M | $4.09M | $3.24M | $3.24M | $2.10M |
| -应付税款合计 | $14.81M | $13.11M | $10.92M | $10.92M | $9.54M |
| 一年内应计费用 | $100.81M | $85.63M | $83.44M | $83.44M | $74.65M |
| 短期债务及融资租赁负债 | $1.81M | $1.80M | $1.77M | $1.77M | $1.70M |
| -一年内到期融资租赁负债 | $1.81M | $1.80M | $1.77M | $1.77M | $1.70M |
| 其他流动负债 | $3.43M | $3.18M | $3.58M | $3.58M | $3.28M |
| 非流动负债合计 | $14.13M | $12.44M | $11.29M | $11.29M | $10.95M |
| 长期债务及融资租赁负债 | $7.05M | $7.31M | $7.57M | $7.57M | $7.81M |
| -长期融资租赁负债 | $7.05M | $7.31M | $7.57M | $7.57M | $7.81M |
| 其他非流动负债 | $7.08M | $5.12M | $3.72M | $3.72M | $3.14M |
| 股东权益合计 | $1.36B | $1.28B | $1.22B | $1.22B | $1.14B |
| 股东权益 | $1.36B | $1.28B | $1.22B | $1.22B | $1.14B |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.23B | $1.20B | $1.19B | $1.19B | $1.16B |
| 留存收益 | $134.86M | $80.10M | $24.16M | $24.16M | -$27.24M |
| 不影响留存收益的损益 | -$4.34M | -$1.62M | $1.14M | $1.14M | $1.10M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $74.79M | $80.38M | $200.87M | $77.51M | $39.66M |
| 持续经营经营活动现金流净额 | $74.79M | $80.38M | $200.87M | $77.51M | $39.66M |
| 持续经营净利润 | $54.77M | $55.93M | $204.83M | $51.40M | $79.36M |
| 持续经营损益 | -$748,000.00 | -$529,000.00 | -$5.95M | -$404,000.00 | -$1.29M |
| 折旧、折耗与摊销 | $1.57M | $1.73M | $6.55M | $1.76M | $1.61M |
| 其他非现金项目 | $174,000.00 | $136,000.00 | $684,000.00 | $289,000.00 | -$295,000.00 |
| 营运资金变动 | $5.62M | $10.08M | -$36.42M | $9.50M | -$27.88M |
| -应收款变动 | -$11.97M | $58,000.00 | -$22.12M | $2.49M | -$17.92M |
| -存货变动 | -$958,000.00 | -$243,000.00 | -$6.29M | -$1.06M | -$4.71M |
| -预付资产变动 | -$4.86M | $1.67M | -$14.66M | -$245,000.00 | -$11.46M |
| -应付账款及应计费用变动 | $21.64M | $7.40M | $4.95M | $7.91M | $6.02M |
| -其他流动负债变动 | $1.77M | $1.21M | $1.70M | $397,000.00 | $195,000.00 |
| 投资活动现金流净额 | -$161.58M | -$63.58M | -$58.42M | $11.16M | -$4.29M |
| 持续经营投资活动现金流净额 | -$161.58M | -$63.58M | -$58.42M | $11.16M | -$4.29M |
| 固定资产购置及出售净额 | -$3.57M | -$7.15M | -$11.95M | -$2.14M | -$1.70M |
| 投资购置及出售净额 | -$158.02M | -$56.44M | -$46.90M | $13.30M | -$2.58M |
| 筹资活动现金流 | $15.05M | -$10.46M | $8.71M | $15.67M | $3.71M |
| 持续经营筹资活动现金流净额 | $15.05M | -$10.46M | $8.71M | $15.67M | $3.71M |
| 股票期权行使所得 | $15.16M | $6.50M | $22.66M | $15.69M | $3.71M |
| 其他筹资费用净额 | -$108,000.00 | -$16.96M | -$13.96M | -$23,000.00 | -$5,000.00 |
| 期末现金余额 | $427.74M | $501.31M | $496.30M | $496.30M | $392.60M |
| 现金净变动 | -$71.74M | $6.34M | $151.15M | $104.34M | $39.08M |
| 期初现金余额 | $501.31M | $496.30M | $344.87M | $392.60M | $353.83M |
| 汇率变动影响 | -$1.83M | -$1.33M | $286,000.00 | -$637,000.00 | -$307,000.00 |
| 自由现金流 | $71.22M | $73.23M | $188.91M | $75.37M | $37.96M |
| 递延税款 | – | – | -$22.85M | $1.84M | – |
| 其他投资变动净额 | – | – | $435,000.00 | $0.00 | $0.00 |
| 普通股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 KRYS。
登录后参与讨论。